S. Szu

发表

Conformational differences among mono- and oligosaccharide fragments of O-specific polysaccharides of Vibrio cholerae O1 revealed by circular dichroism.

P. Kováč, J. Zhang, S. Bystrický, 1998, Carbohydrate research.

Serum antibody response in adult volunteers elicited by injection of Streptococcus pneumoniae type 12F polysaccharide alone or conjugated to diphtheria toxoid

S. Szu, A. Fattom, J. Mestecky, 1990, Infection and immunity.

Bacterial polysaccharide–protein conjugate vaccines

S. Szu, R. Schneerson, J. Robbins, 1999 .

Vi-CRM 197 as a new conjugate vaccine against Salmonella Typhi.

R. Rappuoli, S. Szu, A. Saul, 2011, Vaccine.

Safety and immunogenicity of Escherichia coli O157 O-specific polysaccharide conjugate vaccine in 2-5-year-old children.

Y. Shiloach, S. Szu, Jianping Li, 2006, The Journal of infectious diseases.

The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children.

J. Shiloach, D. D. Trach, S. Szu, 2001, The New England journal of medicine.

Clinical Studies of Escherichia coli O157:H7 Conjugate Vaccines in Adults and Young Children

S. Szu, Amina Ahmed, 2014, Microbiology spectrum.

Temperature‐dependent conformational transitions in poly(dG‐dC) and poly(dG‐m5dC)

M. Behe, G. Felsenfeld, S. Szu, 1985, Biopolymers.

Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children.

S. Szu, R. Schneerson, J. Robbins, 2003, The New England journal of medicine.

Re-examination of immune response and estimation of anti-Vi IgG protective threshold against typhoid fever-based on the efficacy trial of Vi conjugate in young children.

S. Szu, K. Klugman, Steven Hunt, 2014, Vaccine.

Phase 1 Evaluation of Vibrio choleraeO1, Serotype Inaba, Polysaccharide-Cholera Toxin Conjugates in Adult Volunteers

David N. Taylor, S. Szu, J. Robbins, 1998, Infection and Immunity.

Effect of Dosage on Immunogenicity of a Vi Conjugate Vaccine Injected Twice into 2- to 5-Year-Old Vietnamese Children

J. Shiloach, D. D. Trach, S. Szu, 2004, Infection and Immunity.

Investigational vaccine for Escherichia coli O157: phase 1 study of O157 O-specific polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A conjugates in adults.

J. C. Parke, S. Szu, J. Robbins, 1998, The Journal of infectious diseases.

Phase 1 and Phase 2 Studies of Salmonella enterica Serovar Paratyphi A O-Specific Polysaccharide-Tetanus Toxoid Conjugates in Adults, Teenagers, and 2- to 4-Year-Old Children in Vietnam

D. D. Trach, S. Szu, Jianping Li, 2000, Infection and Immunity.

Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid with emphasis on the role of O acetyls

J. Shiloach, S. Szu, J. Robbins, 1996, Infection and immunity.

Conformational Energy Minimization in the Approximation of Limited Range Interactions

R. Jernigan, S. Szu, 1979 .

Birth weight predicts response to vaccination in adults born in an urban slum in Lahore, Pakistan.

A. Prentice, S. Moore, S. Szu, 2004, The American journal of clinical nutrition.

Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin

R. Gupta, S. Szu, R. Finkelstein, 1992, Infection and immunity.

Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A

J. Shiloach, S. Szu, A. Fattom, 1990, Infection and immunity.

Safety and Immunogenicity of Vi Conjugate Vaccines for Typhoid Fever in Adults, Teenagers, and 2- to 4-Year-Old Children in Vietnam

D. D. Trach, S. Szu, R. Schneerson, 1999, Infection and Immunity.

Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals

S. Szu, R. Schneerson, J. Robbins, 1987, The Journal of experimental medicine.

Covalent linkage between the capsular polysaccharide and the cell wall peptidoglycan of Streptococcus pneumoniae revealed by immunochemical methods.

S. Szu, U. Sørensen, J. Henrichsen, 1990, Microbial pathogenesis.

A bivalent vaccine to protect against Streptococcus pneumoniae and Salmonella typhi.

S. Sayeed, R. Malley, S. Szu, 2012, Vaccine.

Development of Vi conjugate – a new generation of typhoid vaccine

S. Szu, 2013, Expert review of vaccines.

Immunochemical characterization of synthetic hexa-, octa- and decasaccharide conjugate vaccines for Vibrio cholerae O:1 Serotype Ogawa with emphasis on antigenic density and chain length

S. Szu, V. Nelson, P. Ftácek, 2013, Glycoconjugate Journal.

Physical and Chemical Characterization and Immunologic Properties of Salmonella enterica Serovar Typhi Capsular Polysaccharide-Diphtheria Toxoid Conjugates

C. Czerkinsky, J. Clemens, S. Szu, 2009, Clinical and Vaccine Immunology.

Relation between structure and immunologic properties of the Vi capsular polysaccharide

S. Szu, J. Robbins, A. Stone, 1991, Infection and immunity.

Relation betweenStructure andImmunologic Properties oftheVi Capsular Polysaccharide

S. Szu, A. Stone, 1991 .

polysaccharide-protein conjugate vaccines. Escherichia coli O157 O-specific immunological properties in mice of Preparation, characterization, and

J. Shiloach, S. Szu, J. Robbins, 2013 .

Preparation, characterization, and immunological properties in mice of Escherichia coli O157 O-specific polysaccharide-protein conjugate vaccines

J. Shiloach, S. Szu, J. Robbins, 1994, Infection and immunity.

Hypothesis: how licensed vaccines confer protective immunity.

S. Szu, R. Schneerson, J. Robbins, 1996, Advances in experimental medicine and biology.

Revaccination does not improve an observed deficit in antibody responses in Pakistani adults born of a lower birth weight.

A. Prentice, S. Moore, S. Szu, 2008, Vaccine.

Syntheses and Immunologic Properties ofEscherichia coli O157 O-Specific Polysaccharide and Shiga Toxin 1 B Subunit Conjugates in Mice

J. Shiloach, S. Calderwood, S. Szu, 1999, Infection and Immunity.

Vaccines for Prevention of Enteric Bacterial Infections Caused by Salmonellae

David N. Taylor, S. Szu, R. Schneerson, 1993 .

Application of optical properties of the Vi capsular polysaccharide for quantitation of the Vi antigen in vaccines for typhoid fever

S. Szu, A. Stone, 1988, Journal of clinical microbiology.

Rabbit antibodies to the cell wall polysaccharide of Streptococcus pneumoniae fail to protect mice from lethal challenge with encapsulated pneumococci

S. Szu, R. Schneerson, J. Robbins, 1986, Infection and immunity.

Comparative immunogenicities of Vi polysaccharide-protein conjugates composed of cholera toxin or its B subunit as a carrier bound to high- or lower-molecular-weight Vi

S. Szu, R. Schneerson, J. Robbins, 1989, Infection and immunity.

Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines

J. Shiloach, S. Szu, D. N. Taylor, 1994, Infection and immunity.

Synthesis and immunological properties of Vi and di-O-acetyl pectin protein conjugates with adipic acid dihydrazide as the linker

J. Shiloach, S. Bystrický, S. Szu, 1997, Infection and immunity.

Cross-Immunogenicity of Pneumococcal Group 9 Capsular Polysaccharides in Adult Volunteers

J. C. Parke, S. Szu, J. Robbins, 1982, Infection and immunity.

Immunochemical characterization of cross-reactivity of pneumococcal group 9 capsular polysaccharide types 9N, 9A, 9L, and 9V

D. Carlo, S. Szu, J. Henrichsen, 1981 .

Stabilization of Regular Conformational Regions in Proteins by Intraregion Electrostatic Interactions

R. Jernigan, S. Miyazawa, S. Szu, 1980 .

Ultrasonic irradiation of bacterial polysaccharides. Characterization of the depolymerized products and some applications of the process.

G. Zon, S. Szu, R. Schneerson, 1986, Carbohydrate research.

Hydrolytic stability of pneumococcal group 6 (type 6A and 6B) capsular polysaccharides

G. Zon, S. Szu, J. Robbins, 1982, Infection and immunity.

Induction of Serum Vibriocidal Antibodies by O-Specific Polysaccharide-Protein Conjugate Vaccines for Prevention of Cholera

S. Szu, J. Robbins, R. Gupta, 1994 .

Vibrio cholerae O139 Conjugate Vaccines: Synthesis and Immunogenicity of V. cholerae O139 Capsular Polysaccharide Conjugates with Recombinant Diphtheria Toxin Mutant in Mice

J. Shiloach, David N. Taylor, S. Szu, 2000, Infection and Immunity.

Development of O-specific polysaccharide-protein conjugates is based upon the protective effect of serum vibriocidal antibodies against cholera

P. Kováč, S. Szu, D. N. Taylor, 1995 .

Characterization of colominic acid by circular dichroism and viscosity analysis.

S. Bystrický, S. Szu, V. Pavliak, 1997, Biophysical chemistry.

Synthesis and physicochemical and immunological characterization of pneumococcus type 12F polysaccharide-diphtheria toxoid conjugates

S. Szu, A. Fattom, A. Sutton, 1988, Infection and immunity.

Evaluation of monophosphoryl lipid A (MPL) as an adjuvant. Enhancement of the serum antibody response in mice to polysaccharide-protein conjugates by concurrent injection with MPL.

S. Szu, A. Fattom, R. Schneerson, 1991, Journal of immunology.

A human IgG anti-Vi reference for Salmonella typhi with weight-based antibody units assigned.

S. Szu, R. Schneerson, J. Robbins, 2013, Vaccine.

Polysaccharide-Based Conjugate Vaccines for Enteric Bacterial Infections: Typhoid Fever, Nontyphoidal Salmonellosis and Escherichia coli O157:H7

S. Szu, R. Schneerson, J. Robbins, 2009 .

Early-life and contemporaneous nutritional and environmental predictors of antibody response to vaccination in young Gambian adults

A. Prentice, S. Moore, D. Goldblatt, 2012, Vaccine.

Chemical structure of and immune response to polysaccharides of Streptococcus pneumoniae.

S. Szu, B. Fraser, C. Lee, 1981, Reviews of infectious diseases.

Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid

J. Shiloach, S. Szu, R. Schneerson, 1991, Infection and immunity.

Evaluation of synthetic schemes to prepare immunogenic conjugates of Vibrio cholerae O139 capsular polysaccharide with chicken serum albumin

S. Szu, Z. Kossaczká, 2000, Glycoconjugate Journal.

Inclusion of a universal tetanus toxoid CD4(+) T cell epitope P2 significantly enhanced the immunogenicity of recombinant rotavirus ΔVP8* subunit parenteral vaccines.

Dianjun Cao, Lijuan Yuan, S. Szu, 2014, Vaccine.

Construction and characterization of human rotavirus recombinant VP8* subunit parenteral vaccine candidates.

Dianjun Cao, S. Szu, Jianping Li, 2012, Vaccine.

DNA conformational kinetics

R. Jernigan, S. Szu, 1979, Biopolymers.

Comparative immunogenicity of conjugates composed of Escherichia coli O111 O-specific polysaccharide, prepared by treatment with acetic acid or hydrazine, bound to tetanus toxoid by two synthetic schemes

R. Gupta, S. Szu, J. Robbins, 1995, Infection and immunity.

Vietnam Teenagers , and 2-to 4-Year-Old Children in Vaccines for Typhoid Fever in Adults , Safety and Immunogenicity of Vi Conjugate

D. D. Trach, S. Szu, R. Schneerson, 1999 .

Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum.

S. Szu, R. Schneerson, J. Robbins, 1995, The Journal of infectious diseases.

Circular dichroism of the O-specific polysaccharide of Vibrio cholerae O1 and some related derivatives.

P. Kováč, S. Bystrický, S. Szu, 1995, Carbohydrate Research.

O-acetylation affects the binding properties of the carboxyl groups on the Vi bacterial polysaccharide.

S. Bystrický, S. Szu, 1994, Biophysical chemistry.

On the Antigenic Determinants of the Lipopolysaccharides of Vibrio cholerae O:1, Serotypes Ogawa and Inaba*

P. Kováč, S. Bystrický, S. Szu, 1998, The Journal of Biological Chemistry.

Phase I clinical trial of O-acetylated pectin conjugate, a plant polysaccharide based typhoid vaccine.

S. Szu, C. Chu, N. D. Thinh, 2014, Vaccine.

Physical, chemical, antigenic, and immunologic characterization of polygalacturonan, its derivatives, and Vi antigen from Salmonella typhi.

S. Bystrický, S. Szu, 2003, Methods in enzymology.

Synthesis and some immunologic properties of an O-acetyl pectin [poly(1-->4)-alpha-D-GalpA]-protein conjugate as a vaccine for typhoid fever

S. Bystrický, S. Szu, J. Robbins, 1994, Infection and immunity.

Application ofOptical Properties oftheViCapsular Polysaccharide forQuantitation oftheViAntigen inVaccines forTyphoid Fever

S. Szu, A. Stone, 1988 .

Chimeric Vaccines Against Japanese Encephalitis, Dengue, and West Nile

F. Guirakhoo, T. Monath, R. Rappuoli, 2004 .

Protection against pneumococcal infection in mice conferred by phosphocholine-binding antibodies: specificity of the phosphocholine binding and relation to several types

S. Clarke, S. Szu, J. Robbins, 1983, Infection and immunity.

An outbreak of Salmonella Paratyphi A in a boarding school: a community-acquired enteric fever and carriage investigation

S. Szu, J. Zhang, J. Gong, 2010, Epidemiology and Infection.

Characterization of a human monoclonal immunoglobulin M (IgM) antibody (IgMBEN) specific for Vi capsular polysaccharide of Salmonella typhi

K. G. Nickerson, E. Kabat, S. Bystrický, 1995, Infection and immunity.

The Vi Conjugate Typhoid Vaccine Is Safe, Elicits Protective Levels of IgG Anti-Vi, and Is Compatible with Routine Infant Vaccines

S. Szu, R. Schneerson, J. Robbins, 2011, Clinical and Vaccine Immunology.

Prediction of β‐sheets in immunoglobulin chains. Comparison of various methods and an expanded 20 × 20 table for evaluation of the effects of nearest‐neighbors on conformations of middle amino acids in proteins

T. T. Wu, H. Bilofsky, E. Kabat, 1978 .

Composite predictions of secondary structures of lac repressor

T. T. Wu, E. Kabat, R. Jernigan, 1979, Biopolymers.

Fluctuation‐dissipation theorems on the basis of hydrodynamic propagators

H. Szu, J. Hermans, S. Szu, 1974 .

Immunochemical characterization of synthetic hexa-, octa- and decasaccharide conjugate vaccines for Vibrio cholerae O:1 Serotype Ogawa with emphasis on antigenic density and chain length

S. Szu, V. Nelson, P. Ftácek, 2013, Glycoconjugate Journal.

Immunochemical Characterization of Cross-Reactivity of Pneumococcal Group 9 Capsular Polysaccharide Types 9N, 9A, 9L, and 9V

D. Carlo, S. Szu, J. Henrichsen, 1981, Infection and immunity.

Protection against pneumococcal infection in mice conferred by phosphocholine-binding antibodies: specificity of the phosphocholine binding and relation to several types

S. Clarke, S. Szu, J. Robbins, 1983, Infection and immunity.

The Vi Conjugate Typhoid Vaccine Is Safe, Elicits Protective Levels of IgG Anti-Vi, and Is Compatible with Routine Infant Vaccines

S. Szu, R. Schneerson, J. Robbins, 2011, Clinical and Vaccine Immunology.

Rotatory Brownian motion of a rigid dumbbell

J. Hermans, S. Szu, 1974, Journal of Fluid Mechanics.

Hydrodynamic interaction for time‐dependent motions: Steady rotation of a rigid dumbbell

J. Hermans, S. Szu, 1973 .

Early-life and contemporaneous nutritional and environmental predictors of antibody response to vaccination in young Gambian adults

A. Prentice, S. Moore, D. Goldblatt, 2012, Vaccine.

Determination of 2-keto-3-deoxyoctulosonic acid (KDO) with high-performance anion-exchange chromatography (HPAEC): survey of stability of KDO and optimal hydrolytic conditions.

S. Szu, Y. Lee, J. Kiang, 1997, Analytical biochemistry.